Cite
HARVARD Citation
Rapoport, B. et al. (n.d.). Her-2 positive and TNBC patients receiving neoadjuvant chemotherapy are associated with a high pathological complete response rate – results from real-world outcomes in a multidisciplinary setting. Breast. pp. S50-S51. [Online].